Exam Preview
Exam Preview
Innovations in Hearing Care from NAL, in partnership with the National Acoustic Laboratories
Please note: exam questions are subject to change.
|
1. In simple terms, what is the underlying philosophy of the NAL prescriptions (NAL-NL2 and NAL-NL3)?
|
||
|
2. Analysis of large sets of fitting data and clinical insights led to which key improvement(s) in the NAL-NL3 prescription?
|
||
|
3. Survey responses from hearing healthcare providers indicated which of the following improvements were desired in an updated NAL-NL3 prescription?
|
||
|
4. The NAL-NL3 Comfort-in-Noise Module (NAL-NL3 CIN) is intended to be used in which of the following ways?
|
||
|
5. The NAL-NL3 Minimal Hearing Loss Module (NAL-NL3 MHL) uses which of the following information to calculate a patient’s amplification targets?
|
||
|
6. Which feature most clearly distinguishes COSI from standardised communication needs questionnaires such as the HHIE or APHAB?
|
||
|
7. Which statement best reflects the primary difference between traditional research and design-led product development in healthcare?
|
||
|
8. Which type of study is primarily designed to determine whether a tool, instrument, or model accurately measures what it is intended to measure?
|
||
|
9. How do patients access the COSI 2.0?
|
||
|
10. Which of the following statements is correct?
|